SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trustmanic who wrote (137)12/9/1997 10:54:00 AM
From: burner   of 193
 
Some expert! If I was I would be getting into the stock now--not before!
This division is not manufacturing generic drugs. I forget the name of the division,and I have thrown away my old documents on Helix but I believe this division supplied diagnostic test kits and has always been only a very small piece of the "Helix". It is a leftover from the days of the merger with biotech and Intercon.
It is widely felt the company needs focus---I agree, to an extent. I think if the company were to establish itself in the DNA arena as a predominant player there would be less impact from the constituent components which round out the company. Major health companies tend to be very diversified but I believe the trick is becoming an established entity first. The name has to get out--one reason I thought it prudent that the corporate name appear on all product ie Pro-lax.
Regards,
Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News